the amount of the transitory form in patients with benign tumors and tumor-like processes in the ovaries ( 4.5-23.5 % ) , hydatidiform mole ( 25 % ) , uterine myoma ( 2-12.6 % ) rose insignificantly ( 5 +/- 2 % in control ) and increased in patients with initial stages of malignant tumors of the ovaries and uterus ( 28.9-43.7 % ) .
C0042133
uterine myoma
C0042149
uterus